|
1
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pasculli B, Barbano R and Parrella P:
Epigenetics of breast cancer: Biology and clinical implication in
the era of precision medicine. Semin Cancer Biol. 51:22–35. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jovanovic J, Rønneberg JA, Tost J and
Kristensen V: The epigenetics of breast cancer. Mol Oncol.
4:242–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Messier TL, Gordon JA, Boyd JR, Tye CE,
Browne G, Stein JL, Lian JB and Stein GS: Histone H3 lysine 4
acetylation and methylation dynamics define breast cancer subtypes.
Oncotarget. 7:5094–5109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tachibana M, Sugimoto K, Fukushima T and
Shinkai Y: Set domain-containing protein, G9a, is a novel
lysine-preferring mammalian histone methyltransferase with
hyperactivity and specific selectivity to lysines 9 and 27 of
histone H3. J Biol Chem. 276:25309–25317. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim K, Son MY, Jung CR, Kim DS and Cho HS:
EHMT2 is a metastasis regulator in breast cancer. Biochem Biophys
Res Commun. 496:758–762. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang YF, Zhang J, Su Y, Shen YY, Jiang DX,
Hou YY, Geng MY, Ding J and Chen Y: G9a regulates breast cancer
growth by modulating iron homeostasis through the repression of
ferroxidase hephaestin. Nat Commun. 8:2742017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park SE, Yi HJ, Suh N, Park YY, Koh JY,
Jeong SY, Cho DH, Kim CS and Hwang JJ: Inhibition of EHMT2/G9a
epigenetically increases the transcription of Beclin-1 via an
increase in ROS and activation of NF-κB. Oncotarget. 7:39796–39808.
2016.PubMed/NCBI
|
|
10
|
Lee JY, Lee SH, Heo SH, Kim KS, Kim C, Kim
DK, Ko JJ and Park KS: Novel Function of Lysine Methyltransferase
G9a in the Regulation of Sox2 Protein Stability. PLoS One.
10:e01411182015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miura S, Maesawa C, Shibazaki M, Yasuhira
S, Kasai S, Tsunoda K, Maeda F, Takahashi K, Akasaka T and Masuda
T: Immunohistochemistry for histone h3 lysine 9 methyltransferase
and demethylase proteins in human melanomas. Am J Dermatopathol.
36:211–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong X, Chen X, Guan X, Zhang H, Ma Y,
Zhang S, Wang E, Zhang L and Han Y: Overexpression of G9a and MCM7
in oesophageal squamous cell carcinoma is associated with poor
prognosis. Histopathology. 66:192–200. 2015. View Article : Google Scholar
|
|
13
|
Chandra D, Choy G and Tang DG: Cytosolic
accumulation of HSP60 during apoptosis with or without apparent
mitochondrial release: Evidence that its pro-apoptotic or
pro-survival functions involve differential interactions with
caspase-3. J Biol Chem. 282:31289–31301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ghosh JC, Dohi T, Kang BH and Altieri DC:
Hsp60 regulation of tumor cell apoptosis. J Biol Chem.
283:5188–5194. 2008. View Article : Google Scholar
|
|
15
|
Kaigorodova EV and Bogatyuk MV: Heat shock
proteins as prognostic markers of cancer. Curr Cancer Drug Targets.
14:713–726. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Cho HS, Lee JJ, Jun SY, Ahn JH,
Min JS, Yoon JY, Choi MH, Jeon SJ, Lim JH, et al: Plasma glutamate
carboxypeptidase is a negative regulator in liver cancer
metastasis. Oncotarget. 7:79774–79786. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ciriello G, Gatza ML, Beck AH, Wilkerson
MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, et
al TCGA Research Network: Comprehensive Molecular Portraits of
Invasive Lobular Breast Cancer. Cell. 163:506–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung KB, Lee H, Son YS, Lee JH, Cho HS,
Lee MO, Oh JH, Lee J, Kim S, Jung CR, et al: In vitro and in vivo
imaging and tracking of intestinal organoids from human induced
pluripotent stem cells. FASEB J. 32:111–122. 2018. View Article : Google Scholar
|
|
19
|
Jung KB, Lee H, Son YS, Lee MO, Kim YD, Oh
SJ, Kwon O, Cho S, Cho HS, Kim DS, et al: Interleukin-2 induces the
in vitro maturation of human pluripotent stem cell-derived
intestinal organoids. Nat Commun. 9:30392018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim DS, Ryu JW, Son MY, Oh JH, Chung KS,
Lee S, Lee JJ, Ahn JH, Min JS, Ahn J, et al: A liver-specific gene
expression panel predicts the differentiation status of in vitro
hepatocyte models. Hepatology. 66:1662–1674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Son MY, Jung CR, Kim DS and Cho HS:
Comparative in silico profiling of epigenetic modifiers in human
tissues. Mol Biol Rep. 45:309–314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ryu JW, Kim SK, Son MY, Jeon SJ, Oh JH,
Lim JH, Cho S, Jung CR, Hamamoto R, Kim DS, et al: Novel prognostic
marker PRMT1 regulates cell growth via downregulation of CDKN1A in
HCC. Oncotarget. 8:115444–115455. 2017. View Article : Google Scholar
|
|
23
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al Cancer Genome Atlas Research Network: An Integrated TCGA
Pan-Cancer Clinical Data Resource to Drive High-Quality Survival
Outcome Analytics. Cell. 173:400–416.e11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arya RK, Singh A, Yadav NK, Cheruvu SH,
Hossain Z, Meena S, Maheshwari S, Singh AK, Shahab U, Sharma C, et
al: Anti-breast tumor activity of Eclipta extract in-vitro and
in-vivo: Novel evidence of endoplasmic reticulum specific
localization of Hsp60 during apoptosis. Sci Rep. 5:184572015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang Y, Zhang X, Horton JR, Upadhyay AK,
Spannhoff A, Liu J, Snyder JP, Bedford MT and Cheng X: Structural
basis for G9a-like protein lysine methyltransferase inhibition by
BIX-01294. Nat Struct Mol Biol. 16:312–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lebret T, Watson RW, Molinié V, O’Neill A,
Gabriel C, Fitzpatrick JM and Botto H: Heat shock proteins HSP27,
HSP60, HSP70, and HSP90: Expression in bladder carcinoma. Cancer.
98:970–977. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho HS, Shimazu T, Toyokawa G, Daigo Y,
Maehara Y, Hayami S, Ito A, Masuda K, Ikawa N, Field HI, et al:
Enhanced HSP70 lysine methylation promotes proliferation of cancer
cells through activation of Aurora kinase B. Nat Commun.
3:10722012. View Article : Google Scholar : PubMed/NCBI
|
